en

PRODUCT DETAIL

Tocieta 25 mg

Code 6672E
MA number 16/0164/24-S
Product Form: tbl flm 84x25 mg (blis.OPA/Al/PVC-Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Zentiva, k.s., Czechia
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B LOCAL HEMOSTATICS, COMBINATIONS
B02BX Other systemic hemostatics
B02BX05 Eltrombopag
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 28.06.2024
Validity: 28.06.2029
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Tocieta 25 mg_50 mg_tbl flm_08.2024.pdf  
PIL: PIL_Tocieta 25 mg_50 mg_tbl flm_08.2024.pdf  
Safety feature Yes
Data update: 22.08.2024
eu-flag.png sk-flag.png